AnneMaureenConnollyMD
Child Neurology • Columbus, OHNeuromuscular Medicine
Professor, Pediatrics and Neurology, Nationwide Children's Hospital, The Ohio State University College of Medicine
Dr. Connolly is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
555 S 18th St
Columbus, OH 43205Phone+1 614-722-6200Fax+1 614-722-4565
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Child Neurology, 1987 - 1990- Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 1984 - 1987
Indiana University School of MedicineClass of 1984
Certifications & Licensure
MO State Medical License 1986 - 2026
OH State Medical License 2019 - 2025
FL State Medical License 2012 - 2014
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Clinical Trials
- Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD) Start of enrollment: 2005 Dec 01
- This is a Study to Get More Information About Non Ambulatory Boys & Men With Duchenne Muscular Dystrophy Start of enrollment: 2010 Mar 01
- Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping Start of enrollment: 2012 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Transitioning From Nusinersen to Risdiplam for Spinal Muscular Atrophy in Clinical Practice: A Single-Center Experience.Can Ebru Bekircan-Kurt, Sharmada Subramanian, Shannon Chagat, Samuel J Mackenzie, Megan Iammarino
Muscle & Nerve. 2025-03-01 - Gross motor delays in infants and young boys with Duchenne muscular dystrophy.Linda P Lowes, Natalie F Reash, Megan A Iammarino, Anne M Connolly, Lindsay Pietruszewski
Journal of Neuromuscular Diseases. 2024-11-01 - 2 citationsTaldefgrobep Alfa and the Phase 3 RESILIENT Trial in Spinal Muscular Atrophy.Laurent Servais, Lindsey Lee Lair, Anne M Connolly, Barry J Byrne, Karen S Chen
International Journal of Molecular Sciences. 2024-09-24
Press Mentions
Parent Project Muscular Dystrophy Awards $450,000 to Collaborative Duchenne Muscular Dystrophy Care ProjectsApril 6th, 2021
Local Family with Little One Battling Spinal Muscular Atrophy Says “Miracle Drug” Is Changing Their Daughter’s LifeNovember 13th, 2017
Public Health Cuts Mean over One in Three Councils Close Services Delivering Contraceptive CareNovember 2nd, 2017- Join now to see all
Grant Support
- Clinical Trial Readiness for Children 0-5 years with Congenital Muscular Dystrophy Secondary to LAMA2 MutationsRESEARCH INST NATIONWIDE CHILDREN'S HOSP2023–2028
- Clinical Trial Readiness for Children 0-5 years with Congenital Muscular Dystrophy Secondary to LAMA2 MutationsRESEARCH INST NATIONWIDE CHILDREN'S HOSP2023–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
